Screening men for Chlamydia trachomatis infection: have we fully explored the possibilities?

Area of Science:

• Public Health
• Infectious Diseases
• Sexual Health

Background:

• Genital chlamydial infection is a common, curable sexually transmitted disease in England and Wales.
• It is a leading cause of pelvic inflammatory disease, ectopic pregnancy, and infertility, prompting a focus on women's health.
• Current screening primarily targets secondary prevention in women, not primary prevention of new infections.

Purpose of the Study:

• To review the arguments for and against screening men for genital chlamydial infection.
• To discuss potential strategies for implementing male screening programs.
• To explore how new diagnostic technologies can overcome previous barriers to male screening.

Main Methods:

• Literature review of existing arguments and research on male chlamydia screening.
• Analysis of the impact of nucleic acid amplification tests (NAATs) on screening feasibility.
• Discussion of implementation strategies for male screening programs.

Main Results:

• Screening men offers a primary prevention strategy to reduce chlamydial transmission to women.
• Traditional barriers to male screening, including cost and invasive procedures, are challenged by advancements in diagnostic testing.
• NAATs provide opportunities for more accessible and effective male screening.

Conclusions:

• Screening men for genital chlamydial infection is a viable strategy for primary prevention.
• Technological advancements in diagnostics facilitate the implementation of male screening programs.
• Including men in screening initiatives is crucial for comprehensive chlamydia control and prevention efforts.